Treatment of myoclonus in degenerative disorders

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Myoclonus is common in neurodegenerative disorders and may be in small or large amplitude. In dementia with Lewy bodies, it occurs as moderately sized jerks in about 1/3 of cases. The combination of dementia, early parkinsonism, hallucinations, cognitive fluctuations, and myoclonus is strongly suggestive of the dementia with Lewy body diagnosis. The major differential diagnosis is Alzheimer’s disease, although other diagnoses should be considered. The physiology of the myoclonus is cortical. Treatment should be tailored to the patient’s circumstances. Drugs used for cortical myoclonus are the most useful. Monitoring is necessary for therapeutic response and possible limiting side effects.

Original languageEnglish (US)
Title of host publicationCurrent Clinical Neurology
PublisherHumana Press Inc.
Pages277-280
Number of pages4
DOIs
StatePublished - Jan 1 2019

Publication series

NameCurrent Clinical Neurology
ISSN (Print)1559-0585

Fingerprint

Myoclonus
Lewy Body Disease
Hallucinations
Parkinsonian Disorders
Therapeutics
Neurodegenerative Diseases
Dementia
Alzheimer Disease
Differential Diagnosis
Pharmaceutical Preparations

Keywords

  • Alzheimer’s disease
  • Cortical myoclonus
  • Dementia
  • Levetiracetam
  • Myoclonus, Cortex, Dementia with Lewy bodies
  • Neurodegeneration
  • Neurophysiology
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Caviness, J. N. (2019). Treatment of myoclonus in degenerative disorders. In Current Clinical Neurology (pp. 277-280). (Current Clinical Neurology). Humana Press Inc.. https://doi.org/10.1007/978-3-319-97897-0_63

Treatment of myoclonus in degenerative disorders. / Caviness, John Nathaniel.

Current Clinical Neurology. Humana Press Inc., 2019. p. 277-280 (Current Clinical Neurology).

Research output: Chapter in Book/Report/Conference proceedingChapter

Caviness, JN 2019, Treatment of myoclonus in degenerative disorders. in Current Clinical Neurology. Current Clinical Neurology, Humana Press Inc., pp. 277-280. https://doi.org/10.1007/978-3-319-97897-0_63
Caviness JN. Treatment of myoclonus in degenerative disorders. In Current Clinical Neurology. Humana Press Inc. 2019. p. 277-280. (Current Clinical Neurology). https://doi.org/10.1007/978-3-319-97897-0_63
Caviness, John Nathaniel. / Treatment of myoclonus in degenerative disorders. Current Clinical Neurology. Humana Press Inc., 2019. pp. 277-280 (Current Clinical Neurology).
@inbook{07ac6a0f0b244d96974ccfd19f404aa5,
title = "Treatment of myoclonus in degenerative disorders",
abstract = "Myoclonus is common in neurodegenerative disorders and may be in small or large amplitude. In dementia with Lewy bodies, it occurs as moderately sized jerks in about 1/3 of cases. The combination of dementia, early parkinsonism, hallucinations, cognitive fluctuations, and myoclonus is strongly suggestive of the dementia with Lewy body diagnosis. The major differential diagnosis is Alzheimer’s disease, although other diagnoses should be considered. The physiology of the myoclonus is cortical. Treatment should be tailored to the patient’s circumstances. Drugs used for cortical myoclonus are the most useful. Monitoring is necessary for therapeutic response and possible limiting side effects.",
keywords = "Alzheimer’s disease, Cortical myoclonus, Dementia, Levetiracetam, Myoclonus, Cortex, Dementia with Lewy bodies, Neurodegeneration, Neurophysiology, Treatment",
author = "Caviness, {John Nathaniel}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-3-319-97897-0_63",
language = "English (US)",
series = "Current Clinical Neurology",
publisher = "Humana Press Inc.",
pages = "277--280",
booktitle = "Current Clinical Neurology",

}

TY - CHAP

T1 - Treatment of myoclonus in degenerative disorders

AU - Caviness, John Nathaniel

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Myoclonus is common in neurodegenerative disorders and may be in small or large amplitude. In dementia with Lewy bodies, it occurs as moderately sized jerks in about 1/3 of cases. The combination of dementia, early parkinsonism, hallucinations, cognitive fluctuations, and myoclonus is strongly suggestive of the dementia with Lewy body diagnosis. The major differential diagnosis is Alzheimer’s disease, although other diagnoses should be considered. The physiology of the myoclonus is cortical. Treatment should be tailored to the patient’s circumstances. Drugs used for cortical myoclonus are the most useful. Monitoring is necessary for therapeutic response and possible limiting side effects.

AB - Myoclonus is common in neurodegenerative disorders and may be in small or large amplitude. In dementia with Lewy bodies, it occurs as moderately sized jerks in about 1/3 of cases. The combination of dementia, early parkinsonism, hallucinations, cognitive fluctuations, and myoclonus is strongly suggestive of the dementia with Lewy body diagnosis. The major differential diagnosis is Alzheimer’s disease, although other diagnoses should be considered. The physiology of the myoclonus is cortical. Treatment should be tailored to the patient’s circumstances. Drugs used for cortical myoclonus are the most useful. Monitoring is necessary for therapeutic response and possible limiting side effects.

KW - Alzheimer’s disease

KW - Cortical myoclonus

KW - Dementia

KW - Levetiracetam

KW - Myoclonus, Cortex, Dementia with Lewy bodies

KW - Neurodegeneration

KW - Neurophysiology

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85066894024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066894024&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-97897-0_63

DO - 10.1007/978-3-319-97897-0_63

M3 - Chapter

C2 - 31356293

AN - SCOPUS:85066894024

T3 - Current Clinical Neurology

SP - 277

EP - 280

BT - Current Clinical Neurology

PB - Humana Press Inc.

ER -